| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.14 (Beat by $0.03) |
| EPS GAAP Actual | $0.14 (Beat by $0.03) |
| Revenue Actual | $0.104616B |
| Revenue Surprise | Beat by $104.616M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.14931 |
| EPS GAAP Estimate | $0.14931 |
| Revenue Estimate | $0.115022701B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.9 | 7.97 | 0.88395 | 0.91482 | 1 |
| Dec 2028 | 0.76 | 9.43 | 0.74644 | 0.77251 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.01 | -0.11991 | 0.104616B | 9.36% | -2.6M |
| FQ2 2025 (Jun 2025) | -0.0122 | -0.14681 | 0.10457B | 10.77% | -3.1M |
| FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 0.106004B | 8.82% | 106M |
| FQ4 2024 (Dec 2024) | 0.041 | 0.041 | 0.100361B | 12.31% | 100.36M |
| FQ3 2024 (Sep 2024) | -0.0085 | -0.0085 | 0.09482B | 9.75% | 94.82M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 0.050584B | 100% | 50.58M |
| FQ2 2019 (Jun 2019) | 0 | 0 | 0.050584B | 100% | 50.58M |
| FQ3 2019 (Sep 2019) | 0 | 0 | 0.053486B | 100% | 53.49M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.14931
Consensus Revenue Estimates
0.115022701B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.14004 | -- | 0.13736 | 0.14322 | 2 |
| FQ3 2027 (Sep 2027) | 0.15699 | -- | 0.15204 | 0.16509 | 1 |
| FQ2 2027 (Jun 2027) | 0.14279 | -- | 0.13829 | 0.15015 | 1 |
| FQ1 2027 (Mar 2027) | 0.14727 | -- | 0.14263 | 0.15486 | 1 |
| FQ4 2026 (Oct 2026) | 0.14417 | -- | 0.13914 | 0.15011 | 3 |
| FQ3 2026 (Jul 2026) | 0.14579 | 93.14 | 0.14071 | 0.1518 | 3 |
| FQ2 2026 (Jun 2026) | 0.14927 | 108.17 | 0.14282 | 0.15606 | 3 |
| FQ1 2026 (Mar 2026) | 0.14931 | 79.91 | 0.14286 | 0.1561 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.12B | -- | 0.12B | 0.13B | 3 |
| FQ3 2027 (Sep 2027) | 0.13B | -- | 0.12B | 0.13B | 2 |
| FQ2 2027 (Jun 2027) | 0.12B | -- | 0.12B | 0.13B | 2 |
| FQ1 2027 (Mar 2027) | 0.13B | -- | 0.12B | 0.13B | 2 |
| FQ4 2026 (Oct 2026) | 0.12B | -- | 0.12B | 0.12B | 4 |
| FQ3 2026 (Jul 2026) | 0.12B | 11.05 | 0.11B | 0.12B | 4 |
| FQ2 2026 (Jun 2026) | 0.12B | 10.91 | 0.11B | 0.12B | 2 |
| FQ1 2026 (Mar 2026) | 0.12B | 7.84 | 0.11B | 0.12B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
3
EPS # of in-lines
3
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12991 | 0.01 | -0.11991 | -1199.1% |
| FQ2 2025 (Jun 2025) | 0.13461 | -0.0122 | -0.14681 | 1203.36% |
| FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 100% | |
| FQ4 2024 (Dec 2024) | 0.041 | 0.041 | 100% | |
| FQ3 2024 (Sep 2024) | -0.0085 | -0.0085 | 100% | |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ2 2019 (Jun 2019) | 0 | 0 | NAN% | |
| FQ3 2019 (Sep 2019) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.11B | $0.1B | $-2.6M | -2.49% |
| FQ2 2025 (Jun 2025) | $0.11B | $0.1B | $-3.1M | -2.97% |
| FQ1 2025 (Mar 2025) | $0B | $0.11B | $106M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.1B | $100.36M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.09B | $94.82M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.05B | $50.58M | 100% |
| FQ2 2019 (Jun 2019) | $0B | $0.05B | $50.58M | 100% |
| FQ3 2019 (Sep 2019) | $0B | $0.05B | $53.49M | 100% |